EKB Journal Management System
Keywords = Chronic myeloid leukemia – Tyrosine kinase inhibitors – Major molecular response – Nilotinib – Imatinib
Number of Articles: 1

1

Response of Chronic Myeloid Leukemia's Patient to Different Types of Tyrosine Kinase Inhibitors

Volume 86, December, December 2018, Page 3779-3785
OSAMA A. IBRAHIM, M.D.; RANIA M. HAFEZ, M.D.; MARWA I. KHALAF, M.D.; MARWA A. MAHMOUD, M.Sc.